Skip to main content
TipRanks
Go Ultimate75% OFF

Lakefront Biotherapeutics (LKFT) Stock Price & Analysis

549 Followers

LKFT Stock Chart & Stats

$33.98$0.05(0.15%)
At close: 4:00 PM EST
$27.5$30$32.5Aug 17Aug 31Sep 14Sep 28Oct 12Oct 26Nov 9
Day’s Range
$33.22 - $34.14
52-Week Range
$25.68 - $36.24
Previous Close
$33.93
Volume
N/A
Average Volume (3M)
280.32K
Market Cap
$2.19B
Enterprise Value
-$529.52M
Total Cash (Recent Filing)
$2.22B
Total Debt (Recent Filing)
$3.15M
Price to Earnings (P/E)
4.1
Beta
0.57
Next Earnings
Feb 24, 2027 (Est.)
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Strong Balance Sheet

Minimal debt relative to equity and substantial equity relative to assets give Lakefront financial flexibility. That cushion can support continued investment and help absorb operating volatility without the immediate pressure of heavy interest obligations or refinancing needs.

TTM Profitability

TTM results show very high gross profit and solid operating and net margins, with net income improving versus earlier annual periods. If sustained, this profitability provides internal earnings capacity to fund development and strengthen the business model.

Revenue Growth

The reported 240.8% revenue growth indicates that Lakefront has demonstrated the ability to expand its topline materially. Such scaling can improve operating leverage and broaden the base supporting future earnings, although consistency remains important.

Bears Say

Persistent Cash Burn

Persistent negative operating and free cash flow means reported profits are not translating into cash generation. Continued cash burn can increase reliance on balance-sheet resources, constrain investment choices, and raise execution risk if operating performance weakens.

Inconsistent Profitability

Earlier losses and inconsistent returns make the current profitability profile less predictable than the latest results alone suggest. This history reduces confidence that margins and earnings can remain durable through changing business conditions over the next several quarters.

Recent Revenue Decline

The TTM revenue decline following a strong 2025 step-up indicates that growth has not yet become consistently repeatable. Uneven topline performance can limit operating leverage, complicate planning, and make future earnings less dependable despite current margins.

Lakefront Biotherapeutics News

LKFT FAQ

What was Lakefront Biotherapeutics’s price range in the past 12 months?
Lakefront Biotherapeutics lowest stock price was $25.68 and its highest was $36.24 in the past 12 months.
What is Lakefront Biotherapeutics’s market cap?
Lakefront Biotherapeutics’s market cap is $2.19B.
When is Lakefront Biotherapeutics’s upcoming earnings report date?
Lakefront Biotherapeutics’s next earnings report is estimated for Feb 24, 2027 (not yet confirmed), which is in 100 days.
How were Lakefront Biotherapeutics’s earnings last quarter?
Lakefront Biotherapeutics released its earnings results on Nov 11, 2026. The company reported -$0.044 earnings per share for the quarter, beating the consensus estimate of -$0.367 by $0.323.
Is Lakefront Biotherapeutics overvalued?
According to Wall Street analysts Lakefront Biotherapeutics’s price is currently Undervalued.
Does Lakefront Biotherapeutics pay dividends?
Lakefront Biotherapeutics does not currently pay dividends.
What is Lakefront Biotherapeutics’s EPS estimate?
Lakefront Biotherapeutics’s EPS estimate is -0.70.
How many shares outstanding does Lakefront Biotherapeutics have?
Lakefront Biotherapeutics has 65,897,070 shares outstanding.
What happened to Lakefront Biotherapeutics’s price movement after its last earnings report?
Lakefront Biotherapeutics reported an EPS of -$0.044 in its last earnings report, beating expectations of -$0.367. Following the earnings report the stock price went up 1.77%.
Which hedge fund is a major shareholder of Lakefront Biotherapeutics?
Hedge funds hold Lakefront Biotherapeutics shares: the largest hedge-fund position in Lakefront Biotherapeutics is 72,325,724 shares, and hedge funds increased their holdings by 26.0K shares last quarter.
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology